VJHemOnc
VJHemOnc PodcastEpisodes
Episodes of VJHemOnc Podcast
Mark All
Search Episodes...
In recent years, there has been great emphasis placed on the importance of cardio-oncology, with both cardiologists and hematologists highlighting...The post The importance of cardio-oncology: awareness around the ESC 2022 guidelines & the val
Smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS) are two well-known precursor conditions to multiple myeloma, and the...The post Exploring the possibility of early interception in smoldering myelo
Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of unknown significance (CCUS) are considered precursor diseases to hematologic malignancies,...The post CHIP & CCUS: knowledge gaps, ongoing trials & recommendations
Monoclonal B-cell lymphocytosis (MBL) is a condition characterized by the presence of an abnormal increase in B lymphocytes in the...The post Monoclonal B-cell lymphocytosis: classification, biology and exploring the possibility of early inter
The introduction of CAR-T therapy has revolutionized the myeloma treatment landscape, offering a promising therapeutic approach for patients with relapsed/refractory...The post The impact of CAR-T therapy on the myeloma treatment landscape, pa
While there have been advances in the treatment and management of amyloidosis in recent years, diagnosis remains a challenge due...The post Diagnosing amyloidosis, currently available therapies & the importance of cardio-oncology appeared firs
Although CAR-T cells have revolutionized the treatment of hematological malignancies, there are several important factors that must be addressed regarding...The post Addressing the importance of lymphodepletion, factors contributing to ICAHT &
The treatment landscape of acute lymphoblastic leukemia (ALL) has transformed with the introduction of novel immunotherapeutic agents, including CAR-T cells...The post Updates with the use of CAR-T therapy in ALL: ongoing challenges, strategie
The treatment landscape of acute myeloid leukemia (AML) has transformed in recent years with the introduction of novel targeted agents,...The post Targeted therapy in AML: the growing role of menin inhibitors & clinical trials exploring these
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic neoplasms which can be categorized into lower- and higher-risk disease (LR-MDS;...The post Updates in lower- and higher-risk MDS: challenges, novel agents & key clinical
In the last decade, the treatment landscape of thalassemia has been transformed with the introduction of novel therapies. With several...The post Key updates in thalassemia at ASH 2023: gene therapies, ongoing trials & the value of precision m
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and rare hematological malignancy associated with poor prognosis. Several challenges remain...The post Updates, challenges and novel agents being explored in BPDCN appeared
The treatment and management of patients with multiple myeloma is continually evolving, giving rise to novel prognostic tools and therapeutic...The post Unanswered questions regarding the sequencing of BCMA therapies, the prognostic value of C
In recent years, the treatment landscape of sickle cell disease (SCD) has been revolutionized with the introduction of novel agents,...The post Key updates in sickle cell disease at ASH 2023: disease biology, ongoing trials & the growing role
In recent years, the treatment and management of light chain (AL) amyloidosis has transformed with the introduction of novel agents....The post ASH 2023 highlights: updates in the diagnosis and treatment of amyloidosis appeared first on VJHemO
The treatment of the BCR-ABL1-negative myeloproliferative neoplasms (MPNs), including myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET), has transformed...The post MPN highlights at ASH 2023: novel agents & ongoing
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as...The post iwNHL 2023 Session V: Expanding the CAR platform in NHL appeared first on VJHemOnc.
The biennial International Workshop on Chronic Lymphocytic LeukemiaTM (iwCLL 2023) was held recently in Boston, MA, and brought together experts who...The post iwCLL 2023: The role of continuous BTKis, approaching Richter’s transformation & ad
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as...The post iwNHL 2023 Session IV: Novel therapies in NHL: BTK inhibitors, BTK degraders, and bispecific antib
In recent years, there have been promising therapeutic advances in light chain (AL) amyloidosis, however, several unmet needs remain in...The post Unmet needs in AL amyloidosis, novel treatment strategies being explored, and the role of CHIP a
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as...The post iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL appeared fi
The treatment and management of myeloproliferative neoplasms (MPNs) including myelofibrosis (MF) and polycythemia vera (PV) has transformed in recent years,...The post MPN diagnosis & treatment: novel agents in PV, clinical guidance for the us
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as...The post iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma appeared first on
The 20th International Workshop on Non-Hodgkin Lymphoma (iwNHL 2023) took place in Miami, FL, and brought together leading experts as...The post iwNHL 2023 Session I: Updates on the biology and treatment of T-cell lymphoma appeared first on VJ
The 5th International Workshop on Acute Leukemias (iwAL 2023) took place in San Diego, CA, and brought together leading experts...The post iwAL 2023 Session IV: Transplantation and immunotherapies in AML: improving patient outcomes appeared fi
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us